AIM ImmunoTech Inc.·4

Sep 16, 3:45 PM ET

Equels Thomas K 4

4 · AIM ImmunoTech Inc. · Filed Sep 16, 2024

Insider Transaction Report

Form 4
Period: 2024-09-13
Equels Thomas K
CEO & President
Transactions
  • Purchase

    Common Stock

    2024-09-13$0.31/sh+20,000$6,1601,488,042 total

Documents

1 file
  • 4
    ownership.xmlPrimary